Mutual Fund Update: New Fund Offer (NFO) Mutual Fund Update: New Fund Offer (NFO) DSIJ Intelligence / Saturday, November 23, 2019 / Article rating: 4.3 New Fund Offers (NFOs) that are open for subscription.
Sundaram Global Brand Fund opens for subscription Sundaram Global Brand Fund opens for subscription DSIJ Intelligence / Friday, November 22, 2019 / Article rating: 2.7 Sundaram Mutual has launched a fund of fund scheme that will invest as a feeder fund into the Sundaram Global Brand Fund. Read on to find how to use this fund.
Zydus Cadila receives USFDA approval for two products Zydus Cadila receives USFDA approval for two products DSIJ Intelligence / Friday, November 22, 2019 / Article rating: 3.0 Zydus Cadila has received final approval from THE USFDA to markets lsosorbide Dinitrate Tablets USP (US RLD - Isordil Tablet), in the strengths of 5 mg, 10 mg, 20 mg, 30 mg, and 40 mg, and also for Desonide Cream (US RLD - Desonide Cream), 0.05%.
Market ends the session in red, IT stocks decline Market ends the session in red, IT stocks decline Amir Shaikh / Friday, November 22, 2019 / Article rating: 5.0 Indian equity benchmarks traded weakly throughout the day on Friday and ended the session on a pessimistic note, led by a decline in IT stocks.
Lupin launches connected Smart Device-Adhero in India Lupin launches connected Smart Device-Adhero in India DSIJ Intelligence / Friday, November 22, 2019 / Article rating: 3.0 Lupin has launched 'Adhero', which is the first-of-its-kind, connected smart device in India to track usage pattern of metered dose inhaler (MDI) by patients. The pharma major also announced the rollout of Hydrocortisone Valerate Cream USP, 0.2%, which is for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.
Dr. Reddy's Laboratories announces the launch of Doxercalciferol Injection Dr. Reddy's Laboratories announces the launch of Doxercalciferol Injection DSIJ Intelligence / Friday, November 22, 2019 / Article rating: 3.5 Dr. Reddy's has launched Doxercalciferol Injection, 4 mcg/2 ml (2 mcg/ml) multiple-dose vials, a therapeutic generic equivalent of Hectorol (doxercalciferol) Injection 4 mcg/2 ml (2 mcg/ml) multiple-dose vials, which has been approved by the U.S. Food and Drug Administration (USFDA).
IPO Analysis: CSB Bank IPO Analysis: CSB Bank DSIJ Intelligence / Friday, November 22, 2019 / Article rating: 3.5 CSB Bank, one of the oldest private sector banks in India, with a history of over 98 years, is entering the capital market with its initial public offering. Read on to find if you should subscribe to it.
Coal India to develop new coal mines Coal India to develop new coal mines Amir Shaikh / Friday, November 22, 2019 / Article rating: 5.0 Coal India is planning to develop 55 new coal mines and expand 193 existing ones in the next five years. The company is also undertaking portal-based monitoring of ongoing projects to ensure its timely completion.
Alembic Pharma gets USFDA approval for 3 ANDAs Alembic Pharma gets USFDA approval for 3 ANDAs Apurva Joshi / Friday, November 22, 2019 / Article rating: 5.0 Alembic Pharmaceuticals Limited has received the US Food & Drug Administration (USFDA) approvals for 3 of its ANDAs. It has total of 107 ANDA approvals (95 final approvals and 12 tentative approvals) from the USFDA.
How your financial advisers are getting paid? How your financial advisers are getting paid? DSIJ Intelligence / Friday, November 22, 2019 / Article rating: 4.1 Whether you invest in mutual funds or in stocks, your financial advisers or brokers are paid for the services they provide. But, do you know in what ways you pay them? Let’s find out.